Skip to content

Extremely brief mindfulness interventions for women undergoing breast biopsies: a randomized controlled trial.

Bertha Andrade Coelho, Sara de Pinho Cunha Paiva, Agnaldo Lopes Da Silva Filho

Breast cancer research and treatment July 5, 2018 DOI: 10.1007/s10549-018-4869-9 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Qualitative Peer reviewed
Sample size 82
Population Women undergoing percutaneous imaging-guided breast biopsy
Interventions Mindfulness techniques supportive dialogue
Duration One week before biopsy, in waiting room, and during biopsy procedure
Measures Visual analogue scale for pain, salivary cortisol, blood pressure, heart rate, oxygen saturation, peripheral temperature, questionnaires measuring depression, anxiety and stress
Topics Anxiety Depression Meditation
Keywords Humans Breast neoplasms Pain measurement Treatment outcome Stress, psychological Adult Middle aged Female Surveys and questionnaires Salivary cortisol Breast biopsy Stress markers
Key findings A brief mindfulness intervention was associated with reduced perceived stress, blood pressure, heart rate, and oxygen saturation compared with standard care. No differences were observed in salivary cortisol, peripheral temperature, or pain perception. The authors suggest the intervention is feasible and may reduce discomfort in acutely stressful settings.

Abstract

Purpose: Mindfulness-based programs can reduce stress and help practitioners to have positive attitudes in their daily lives. This randomized controlled trial evaluated the impact of brief Mindfulness interventions on quantitative and qualitative stress parameters in patients undergoing imaging-guided breast biopsies.

Methods: Eighty-two women undergoing percutaneous imaging-guided breast biopsy were randomized into two groups: MBI group or standard care group. One week before the biopsy procedure, on the waiting room and during the biopsy procedure, the MBI group was exposed to mindfulness techniques and the standard care group received supportive dialogue from the biopsy team. Participants completed questionnaires measuring depression, anxiety and stress, demographics, and medical history, besides evaluating their pain experience through a visual analogue scale for pain and had their systolic and diastolic blood pressure, initial and final temperate, heart rate, oxygen saturation, and salivary cortisol measured.

Results: Participation in the mindfulness intervention group was associated with reduced levels of perceived stress, blood pressure, heart rate, and oxygen saturation compared to participation in the standard care group (P values < 0.05). No difference was observed regarding salivary cortisol levels, peripheral temperature, and pain perception between the two studied groups.

Conclusion: Results indicate that an extremely brief mindfulness intervention is a feasible intervention, suggesting that Mindfulness-based programs may be beneficial to reduce discomfort in acutely stressful settings.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics